positive
Recently
OpenAI Invests in Biodefense AI Startup Valthos to Combat Bioengineered Threats
No Image
OpenAI joins Founders Fund and Lux Capital in backing Valthos, an AI-powered biodefense startup combating engineered biological threats through predictive genomic modeling.
OpenAI participated in a $30 million seed round for Valthos, a biodefense startup developing AI systems to detect and neutralize synthetic biological threats. Co-investors include Founders Fund and Lux Capital. The company’s platform applies multimodal AI to genomic datasets to predict and contain engineered pathogens before spread. Analysts call this OpenAI’s first venture into real-world AI safety and biosecurity applications.